Antiretroviral nanoparticles: An extended drug delivery modality

Christopher J. Destache; Michael Goede; Todd Belgum

doi:10.4155/tde.10.42

Back

Antiretroviral nanoparticles: An extended drug delivery modality

Journal article

Peer reviewed

Antiretroviral nanoparticles: An extended drug delivery modality

Christopher J. Destache, Michael Goede and Todd Belgum

Therapeutic delivery, Vol.1(3), pp.383-386

09/2010

DOI: https://doi.org/10.4155/tde.10.42

PMID: 22816141

Abstract

Pharmaceutical Science

The antiretroviral nanoparticle formulation laboratory at Creighton University School of Pharmacy & Health Professions is lead by Chris Destache. Over the past 4 years, this laboratory has been investigating the use of antiretroviral nanoparticles as a sustained drug delivery method for HIV-1-infected patients.

Metrics

7 Record Views

Details

Title: Antiretroviral nanoparticles
Creators: Christopher J. Destache (Author) - Department of Pharmacy Practice
Michael Goede (Author) - Creighton University
Todd Belgum (Author) - Creighton University
Additional links: Savage, Grant; Ford, Eric; Clark, Terry D.; Potter, Joshua D.; Larson, Jennifer M.; Mordeson, John N.; Wierman, Mark J.; Tracy, Steven; Drescher, Kristen; Oberste, Steven
Publication Details: Therapeutic delivery, Vol.1(3), pp.383-386
Series: 1
Number of pages: 4
Identifiers: 991005929588802656
Academic Unit: Pharmacy Practice
Language: English
Resource Type: Journal article

Antiretroviral nanoparticles: An extended drug delivery modality

Abstract

Related links

Metrics

Details